Maria C. Benedetti

PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma

Ombretta Melaiu, Marco Mina, Marco Chierici et al. · Clinical Cancer Research · 2017 · 109 citations · Full text

Life Sciences, Immunology, Oncology +17

IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma

Valentina Folgiero, Evelina Miele, Andrea Carai et al. · Oncotarget · 2016 · 41 citations · Full text

Medicine, Cancer Biology, Oncology +17

<i>CHL1</i>gene acts as a tumor suppressor in human neuroblastoma

Marzia Ognibene, Gabriella Pagnan, Danilo Marimpietri et al. · Oncotarget · 2018 · 29 citations · Full text

Medicine, Cancer Biology, Oncology +17

Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors

Renata Boldrini, Maria Debora De Pasquale, Ombretta Melaiu et al. · OncoImmunology · 2018 · 29 citations · Full text

Medicine, Immunology, Oncology +17

Allogeneic HSCT transfers wild-type cystinosin to nonhematological epithelial cells in cystinosis: First human report

Mohamed A. Elmonem, Koenraad Veys, Fanny Oliveira Arcolino et al. · American Journal of Transplantation · 2018 · 25 citations · Full text

Medicine, Cell Biology, Pharmacology +12